Skip to content
Scientific and commercial acceptance of the use of psychedelics as treatments for PTSD, anxiety, and other mental disorders has created an exciting new field […]
Industry, regulators opening their minds to psychedelics as treatments Read More »
Rachel King was enjoying her retirement. When the COVID-19 pandemic hit, King found herself with a chance to refocus and ask herself what was
Meet Rachel King, BIO’s new interim CEO and a champion of the biotech industry Read More »
As the weather is getting colder with the winter months approaching, the very scary possibility of a “twindemic” of COVID-19 and influenza we’ve discussed
RSV, COVID, and flu ‘tripledemic’ risk runs high Read More »
According to the National Confectioners Association (NCA), 93% of Americans plan to celebrate the 2022 Halloween season. What’s more, the NCA projects an increase
This Halloween, biotech is making your candy haul more sustainable Read More »
On Day 2 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit, a panel titled Implementing Legislation—Engaging CMS dug into the importance
How patient advocates can engage with CMS Read More »
What did we learn on Day 1 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit in Washington, D.C.? It’s all about
What we learned on Day 1 of the Patient and Health Advocacy Summit Read More »
Every member of the Council of State Bioscience Associations (CSBA) signed a letter to President Biden expressing serious concerns with the proposed expansion of a
Expanding WTO IP waiver would hurt SMEs, CSBA tells Biden Read More »
With issues like Accelerated Approval, anti-vaccine legislation, and biomarkers being taken up in state capitals, these are busy times for patient advocates working at
State policies impacting access to innovative medicine, panel says Read More »
A team of University of Arizona researchers using new knowledge about genes has developed “a drug compound that appears to stop cancer cell growth”
‘Goldilocks drug’ stops triple-negative breast cancer in mice, researchers say Read More »
The Biotechnology Innovation Organization (BIO) kicked off Day One of its two-day Patient and Health Advocacy Summit with a welcome from Eric Dube, President
